Reports Q1 revenue $1.22M, consensus $768K. Reports cash balance of $58.0M as of March 31, which is anticipated to fund key milestones through mid-2026.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOLT:
- Biotech Alert: Searches spiking for these stocks today
- Bolt Biotherapeutics to host KOL call on BDC-3042 Phase 1 results
- Bolt Biotherapeutics announces results for Boltbody ISACs at AACR meeting
- Cautious Hold Rating for Bolt Biotherapeutics Amidst Promising Developments and Uncertainties
- Bolt Biotherapeutics reports Q4 EPS (42c), consensus (35c)